The use of lower or higher than recommended doses of folic acid supplements during pregnancy is associated with child attentional dysfunction at 4-5 years of age in the INMA Project
Ver/ Abrir
Impacto
Scholar |
Otros documentos de la autoría: Compañ Gabucio, Laura M; Garcia de la Hera, Manuela; Torres-Collado, Laura; Fernández Somoano, Ana; Tardon, Adonina; Guxens, Mònica; Vrijheid, Martine; Rebagliato, Marisa; Murcia, Mario; Ibarluzea, Jesus; Martí, Itxaso; Vioque, Jesus
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
The use of lower or higher than recommended doses of folic acid supplements during pregnancy is associated with child attentional dysfunction at 4-5 years of age in the INMA ProjectAutoría
Fecha de publicación
2021-01-23Editor
MDPIISSN
2072-6643Cita bibliográfica
Compañ Gabucio, L.M.; García de la Hera, M.; Torres Collado, L.; Fernández-Somoano, A.; Tardón, A.; Guxens, M.; Vrijheid, M.; Rebagliato, M.; Murcia, M.; Ibarluzea, J.; et al. The Use of Lower or Higher Than Recommended Doses of Folic Acid Supplements during Pregnancy Is Associated with Child Attentional Dysfunction at 4–5 Years of Age in the INMA Project. Nutrients 2021, 13, 327. https://doi.org/10.3390/nu13020327Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
https://pubmed.ncbi.nlm.nih.gov/33498619/Versión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
We assessed the association between the use of lower- and higher-than-recommended doses of folic acid supplements (FAs) during pregnancy and attentional function in boys and girls at age of 4-5. We analyzed data from ... [+]
We assessed the association between the use of lower- and higher-than-recommended doses of folic acid supplements (FAs) during pregnancy and attentional function in boys and girls at age of 4-5. We analyzed data from 1329 mother-child pairs from the mother-child cohort INfancia y Medio Ambiente Project (INMA) study. Information on FAs use during pregnancy was collected in personal interviews at weeks 12 and 30, and categorized in <400, 400-999 (recommended dose), and ≥1000 μg/day. Child attentional function was assessed by Conners' Kiddie Continuous Performance Test. Multivariable regression analyses were used to estimate incidence rate ratios (IRR) and beta coefficients with 95% confidence intervals (CI). Compared to recommended FAs doses, the periconceptional use of <400 and ≥1000 μg/day was associated with higher risk of omission errors-IRR = 1.14 (95% CI: 1.01; 1.29) and IRR = 1.16 (95% CI: 1.02; 1.33), respectively. The use of FAs < 400 μg/day and ≥1000 μg/day was significantly associated with deficits of attentional function only in boys. FAs use < 400 μg/day was associated with higher omission errors with IRR = 1.22 and increased hit reaction time (HRT) β = 34.36, and FAs use ≥ 1000 μg/day was associated with increased HRT β = 33.18 and HRT standard error β = 3.31. The periconceptional use of FAs below or above the recommended doses is associated with deficits of attentional function in children at age of 4-5, particularly in boys. [-]
Publicado en
Nutrients, Volume 13, Issue 2 (February 2021)Entidad financiadora
Instituto de Salud Carlos III | Ministerio de Economía, Industria y Competitividad | Generalitat Valenciana - FISABIO | Generalitat de Catalunya-CIRIT | Obra Social Cajastur/Fundación Liberbank | Universidad de Oviedo | Diputación Foral de Gipuzkoa | Gobierno Vasco. Departamento de Salud
Derechos de acceso
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- MED_Articles [639]
El ítem tiene asociados los siguientes ficheros de licencia: